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PLASMA A C T H IN BULBUS SUPERIOR VENAE JUGULARIS AND 
BIOLOGICAL HALFLIFE O F ENDOGENOUS ACTH 
R . W. H a c k e r , F . Kluge, K. Schwarz and P . C. Scriba 
Plasma ACTH activities were determined by the Lipscomb-Nelson technique. 
In our modification of the technique a linear response of corticosterone secretion per 
8 min. to doses from 0.01 to 1.00 mU ACTH was obtained (limit of sensivity: 0.015 mU, 
index of precision: X — 0.19). 
Using this assay 15 patients with elevated plasma ACTH levels have been studied 
(7 m. Addison, 7 adrenalectomy for Cushing's-syndrome, 1 adreno-genital Syndrome). 
Blood was drawn 10 min. after puncture of bulbus superior venae jugularis and of 
the cubital vein, and plasma prepared by refrigerated centrifugation within 5—8 min. 
and kept frozen until determination, performed no more than 3—4 days later. In 
these 15 patients ACTH levels were 0.600 mU/ml plasma (number of determinations: 
n = 39) in bulbi sup.v.j. and 0.377 mU/ml (n = 38) in cubital veins, the mean differ-
ence being significant (p < 0.01). Plasma ACTH levels are higher in bulbus sup.v.j. 
than in the cubital vein by a quotient ( A ACTH) calculated when the amount of ACTH 
secreted by the pituitary during one half-life for ACTH (numerator) is divided by the 
plasma volume passing the bulbi sup.v.j. within one half-life (numerator). The mean 
biological half-life of endogenous ACTH was calculated as 53.8 min. using the equation: rVolume of distribution 
A ACTH = 
X TPeripheral 1 
LACTH J [ACTH level J 
where: 
[Cerebral plasma 1 x [Biological 1 flow per min. J [halflife ACTHJ 
A ACTH = difference of plasma ACTH levels from bulbus sup.v.j. 
and cubital vein 
Peripheral ACTH level = ACTH in cubital vein. 
Values for volume of distribution of ACTH and for cerebral plasma flow have been 
adopted from the literature ( S c r i b a et al. 1966; 1967). 
Arterio-venous differences have been determined in 8 of the above patients. The 
means of plasma ACTH levels were 0.612 mU/ml (femoral artery, n = 24) and 0.452 
mU/ml (cubital vein, n = 21). The mean a.v. difference was significant (p < 0.025). 
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